“…of subjects > 65 years: 3103 (63.3%) 44.8% F | Hyponatremia related to heart failure, liver cirrhosis, diabetes, malignancy, diuretic use | Dementia diagnosed according to ICD-9-CM | Furosemide, thiazides. Dosage not reported | Hyponatremia as a predictor of dementia | C. Fujisawa et al (2021) [ 49 ] | Prospective cohort | Not reported | Serum sodium < 135 mEq/l | Single at baseline | 2982 | 82.0 (76.0–84.0) in hyponatremic vs 79.0 (75–83) in normonatremic Median years (IQR) | 48% F | Hyponatremia related to cardiac disease, liver disease, diabetes, diuretic use | MMSE, FAB, Digit span forward, Digit span backward, category fluency, logical memory | Type and dosage of diuretics not specified | Association between hyponatremia and cognitive impairment, muscle mass, physical performance |
Gosch et al (2012) [ 13 ] | Case control | 128 ± 3.2 mEq/l (mean ± SD) in hyponatremic group | Serum sodium < 135 mEq/l | Single at admission | 2880 | 78.6 (6.98) Mean years (SD) | 75.6% F | Hypo- (4.7%), and normo-osmolar (1.6%) hyponatremia, adverse drug reaction (15.5%), hyponatremia related to heart failure (3.1%), severe liver disease (0.8%), cancer (1.6%), adrenal insufficiency (1.6%), SIADH (0.8%) | MMSE, clock completion | Type and dosage of diuretic not specified | Effect of hyponatremia on CGA |
Pereira et al (2006) [ 50 ] | Prospective cohort | Not reported | Serum sodium < 135 mEq/l | Single at baseline | 306 | 74 (8.7) Mean years (SD) | 50.33% F | Not evaluated | BLAD | Not evaluated | Frequency of laboratory abnormality in MCI and dementia |
Suárez et al (2020) [ |
…”